White Biotech Market Size, Share & Trends Analysis Report By Type (Biofuels, Biomaterials, Biochemicals, Industrial Enzymes), By Applications (Chemicals, Pharmaceuticals, Food and Beverages, Feed) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

White Biotech Market Size

The global white biotech market size was valued at USD 432.62 billion in 2025 and is projected to grow from USD 458.88 billion in 2026 to USD 735.26 billion by 2034, registering a CAGR of 6.07% during the forecast period from 2026 to 2034. Asia Pacific dominated the white biotech market with a market share of 36.4% in 2025.

Increasing environmental concerns and regulatory pressures are driving industries to adopt sustainable and eco-friendly production processes. White biotechnology offers bio-based alternatives that reduce reliance on fossil fuels and minimize environmental impact.

White biotechnology, also known as industrial biotechnology, is the application of the scientific principles of biotechnology to produce biodegradable and biobased products using biocatalysts like enzymes and microorganisms. Various essential bioactive compounds, secondary metabolites, pigments, organic compounds like citric acid, acetic acid, glycerin, and acetone, as well as antibiotics like penicillin, streptomycin, and mitomycin, are all frequently produced using it. Metabolites, biodegradable plastics, biocontrol agents, biobased fuel, sustainable energy, and waste treatment are also made using it. White biotechnology has numerous uses in various sectors, including bioenergy, textiles, construction, chemicals, food and beverage, and pharmaceuticals.

Type Insights

The market is bifurcated based on type into biofuels, biomaterials, biochemicals, and industrial enzymes. The biochemical segment is the highest contributor to the market and is expected to grow at a CAGR of 16.77% during the forecast period. The biochemical is subdivided into household soap and detergents, personal care products, paper and pulp, and textiles. Tightening regulations, environmental concerns, and consumer demand for more sustainable products contribute to the market's growth. As a result, manufacturers of cleaning products, including those for the home, have been reducing their carbon footprints for years by reducing packaging, upping the proportion of biobased ingredients, and lowering the recommended temperature for product use. To meet the ongoing consumer demand for sustainable products, the global leaders in the household soaps and detergents market are also incorporating biochemicals into their product lineups. For illustration: In Chile, there is a dish soap by Unilever that uses rhamnolipids from Evonik.

Since they lower carbon emissions, qualify for carbon credits, lessen reliance on fossil fuels, and use naturally renewable feedstock, biofuels have drawn much attention in recent years. Aside from these advantages, the market for biofuels is also benefiting from agriculturally based economies like India and Brazil because of the large area available for feedstock production. For the promotion and use of biofuels, the governments of more than 23 nations have released mandates, development plans, policies, and regulations. The United States, Brazil, France, and China consume the most biodiesel, followed by Germany, the United Kingdom, Italy, Spain, Poland, Thailand, and Indonesia.

Request Customizationto receive a tailored report.

Application Insights

The market is bifurcated based on application into chemicals, pharmaceuticals, food and beverages, and feed. The chemicals segment is the highest contributor to the market and is expected to grow at a CAGR of 14.24% during the forecast period. Chemical producers have relied on intricate and frequently harmful processes for years to create a variety of goods, including vitamins, nylon, plastics, natural gas, petroleum, and process chemicals. White biotechnology has, however, been pushed into the industrial sector by recent developments. White biotechnology has grown in significance for the chemical industry, which is under pressure from rising crude oil prices and increasing consumer demand for eco-friendly products. Other factors accelerating white biotechnology in the chemical industry, aside from the rising cost of crude oil and consumer preference for green products, include the quickening pace of technological advancements and the increasing cost of carbon dioxide emissions in manufacturing. White biotechnology processes will be used by chemical manufacturers instead of conventional chemical manufacturing due to growing consumer demand for green chemicals, especially in North America and Europe, where consumers are willing to pay a higher price or a green premium for a variety of renewable products. To expand the chemical market, chemical producers are turning to biochemicals.

White biotech, such as biomaterials in the pharmaceutical industry, is expanding due to the commercial interest of biomedical companies and research funding. Orthopedics, cardiology, wound care, and other areas of the pharmaceutical industry are just a few of the places where biomaterials have found applications. Industrial enzymes, in addition to biomaterials, are promoting the development of white biotech in the pharmaceutical sector. Promoting wound healing, eliminating disease-causing microorganisms, and diagnosing diseases are among the significant uses of pharmaceuticals. The pharmaceutical industry's use of these products is anticipated to be driven by a rising population, consumer demand, and awareness of diseases and their effects. Enzymes employed in this procedure also allow the production of chiral compounds and other difficult-to-synthesize intermediates, like active pharmaceutical ingredients. Over the next eight years, the market is anticipated to be driven by the expansion of the pharmaceutical industry, particularly in Europe.

Speak to an Analystto discuss market opportunities.

Regional Insights

Asia-Pacific is the most significant revenue contributor and is expected to grow at a CAGR of 17.95% during the forecast period. Over the past ten years, China's biotech sector has expanded quickly, and biologics and medical technologies now account for most of its output. The market's availability of biotechnologically modified food ingredients accelerates growth. Players are putting money into local businesses in this way. Additionally, inconsistent potency and subpar product quality, caused by product contamination, hinder the expansion of the Chinese biopharmaceutical and pharmaceutical market. Even after government intervention and tighter quality control regulations, the industry needs more due to ambiguity, a slow approval process, and other administrative procedures in systems that allow for the sale of high-quality pharmaceuticals containing genetically altered ingredients. The country's expanding population and associated food needs created a sizable market opportunity for genetically modified crops.

Unlock Regional Insightsto access country-level data, & regional trends.

North America White Biotech Market Trends

North America is expected to grow at a CAGR of 13.21% during the forecast period. The largest market for biopharmaceuticals is the United States, which represents about one-third of the global market. According to the United States Department of Commerce, it is the worldwide leader in biopharmaceutical R&D. According to the US EIA, 5.2 billion liters of ethanol will be produced in January 2020, so the US government has been funding additional research into "cutting-edge methods" since 2006. The expansion of an on-site enzyme manufacturing (OSM) facility in Emmetsburg, Iowa, was announced by POET-DSM Advanced Biofuels LLC in 2017. The US Department of Agriculture reported in May 2020 that it would provide a grant worth USD 100 million to increase the accessibility and sale of higher ethanol blends. The growing investment in biofuels is anticipated to present lucrative growth opportunities for players in the global white biotechnology market.

• Germany is encouraging new ideas to produce medicines, chemicals, materials, and energy sustainably and economically, and the sudden expansion of some white biotechnology companies is driving the growth in the anticipated period. In addition, BASF invested in LanzaTech, a company that recycles carbon. In addition to ethanol, the company also sells other biochemicals that can be used as raw materials in other chemical production processes, such as chemical specialties and intermediates. Additionally, throughout the forecast period, the market for white biotechnology is anticipated to grow due to the use of biomaterials in the healthcare industry. During the forecast period, the German white biotechnology market is expected to expand faster due to the rising demand for biofuel and biopharmaceutical products.

The Middle East is a significant market. The demand for white biotech will increase during the forecast period due to increased government funding and biochemical product innovation. The biochemical industry is driven by using biomaterials in cardiology, plastic surgery, orthopedic surgery, and neurology. Furthermore, the Middle East has a very high meat consumption rate due to population growth, consumer spending on processed foods, and consumer awareness of the advantages of natural preservatives over chemicals, which has led to the introduction of more novel products on the market. The use of biofuels, which reduces carbon emissions and atmospheric pollution, attracts more partnerships in this industry.

List of Key and Emerging Players in White Biotech Market